Best CDMOs in Europe — Ranked by Signal Score · 2026
128
CDMOs in region
65
Fully scored
22
With FDA records
78
FDA inspections
347
EMA/MHRA GMP certs
CDMO Signal tracks 128 biopharma CDMOs with confirmed Europe manufacturing facilities, of which 65 are fully scored across the four-pillar composite Signal Score. Across all modalities, Charles River Laboratories, Novartis, and ReciBioPharm lead the Europe ranking by composite score. Signal Score integrates FDA inspection history, EMA/MHRA GMP certificate density, ClinicalTrials.gov sponsor footprint, and monitored capacity signals. For modality-specific rankings within Europe — AAV, cell therapy, biologics, and 10 other tracked modalities — see the modality-region breakdown below. Full methodology at cdmosignal.com/methodology.
European CDMOs ranked by CDMO Signal's composite Signal Score, filtered to manufacturers with confirmed EU, UK, or Swiss facilities. This ranking is the subset of our global directory with European manufacturing presence — a CDMO with EU + US + Asia sites appears in each corresponding region ranking. Filtering is derived from each CDMO's declared facility locations.
| # | CDMO | Signal Score | Quality | FDA · GMP | Capacity | Programs |
|---|---|---|---|---|---|---|
| 1 |
CR
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
|
91.7 | 98.7 | 8 insp · 11 GMP | Limited | 0 programs |
| 2 |
Novartis
Basel, Switzerland
|
88.3 | 90.9 | 14 insp · 62 GMP | — | 135 programs |
| 3 |
RP
ReciBioPharm
Keele, UK · Sodertalje, SE
|
88.0 | 100.0 | 0 insp · 3 GMP | — | 0 programs |
| 4 |
BNT
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
|
84.8 | 100.0 | 0 insp · 8 GMP | — | 27 programs |
| 5 |
FD
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
|
83.5 | 100.0 | 0 insp · 23 GMP | 0 programs | |
| 6 |
MN
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
|
83.5 | 100.0 | 1 insp · 6 GMP | Limited | 0 programs |
| 7 |
BA
Bachem
Bubendorf, CH
|
83.5 | 98.9 | 3 insp · 0 GMP | — | 0 programs |
| 8 |
RB
Richter BioLogics
Hamburg, Germany
|
82.9 | 100.0 | 0 insp · 9 GMP | — | 0 programs |
| 9 |
CD
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
|
82.5 | 99.7 | 3 insp · 10 GMP | — | 0 programs |
| 10 |
MK
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
|
81.8 | 98.6 | 2 insp · 2 GMP | — | 22 programs |
| 11 |
WK
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
|
81.6 | 100.0 | 0 insp · 13 GMP | — | 0 programs |
| 12 |
SC
SCTbio
Prague, Czech Republic
|
81.6 | 100.0 | 0 insp · 5 GMP | — | 0 programs |
| 13 |
EF
Eurofins CDMO
Planegg, DE · San Diego, CA
|
81.6 | 100.0 | 5 insp · 0 GMP | — | 0 programs |
| 14 |
BR
BioReliance (Merck)
Glasgow, UK · Rockville, MD
|
81.0 | 98.8 | 4 insp · 8 GMP | — | 0 programs |
| 15 |
AG
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
|
80.6 | 99.9 | 2 insp · 23 GMP | Available | 2 programs |
| 16 |
TK
Takeda
Boston, MA · Zurich, CH
|
80.5 | 99.3 | 4 insp · 18 GMP | — | 100 programs |
| 17 |
CF
CELLforCURE (SEQENS)
Les Ulis, FR
|
80.3 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 18 |
KE
Kaneka Eurogentec
Seraing, BE
|
80.3 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 19 |
RC
RoslinCT
Edinburgh, UK · Hopkinton, MA
|
80.2 | 98.8 | 1 insp · 1 GMP | Available | 0 programs |
| 20 |
RB
Rentschler Biopharma
Laupheim, Germany
|
79.9 | 99.3 | 1 insp · 2 GMP | — | 0 programs |
| 21 |
SK
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
|
79.5 | 100.0 | — | Available | 0 programs |
| 22 |
NV
Novartis Contract Manufacturing
Morris Plains, NJ · Stein, CH
|
79.1 | 90.9 | — | Constrained | 284 programs |
| 23 |
PG
ProBioGen
Berlin, DE
|
78.9 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 24 |
XP
eXmoor Pharma
Bristol, United Kingdom
|
78.7 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 25 |
Lonza
Basel, Switzerland
|
78.2 | 95.1 | 2 insp · 8 GMP | — | 1 programs |
| 26 |
AA
Ascend Advanced Therapies
London, United Kingdom
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 27 |
NG
NecstGen
Leiden, NL
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 28 |
ET
Exothera
Jumet, BE
|
78.1 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 29 |
OR
Ori Biotech
London, UK
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 30 |
CE
Celonic
Basel, Switzerland
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 31 |
AD
Advent Bioservices
London, United Kingdom
|
78.1 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 32 |
SI
Simtra BioPharma Solutions
Bloomington, IN · Halle, DE
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 33 |
BV
Biovian
Turku, Finland
|
78.0 | 99.7 | 1 insp · 4 GMP | — | 0 programs |
| 34 |
OX
Oxford Biomedica
Oxford, United Kingdom
|
77.1 | 100.0 | 0 insp · 13 GMP | Available | 7 programs |
| 35 |
VG
Viralgen Vector Core
San Sebastián, Spain
|
76.8 | 100.0 | 0 insp · 4 GMP | Available | 0 programs |
| 36 |
SY
Symbiosis Pharmaceutical Services
Stirling, United Kingdom
|
76.8 | 100.0 | 1 insp · 9 GMP | — | 0 programs |
| 37 |
CY
Cell-Easy
Toulouse, FR
|
76.8 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 38 |
CN
Cellin Technologies
Luxembourg, LU
|
76.8 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 39 |
HH
HiTech Health
London, United Kingdom
|
76.8 | 100.0 | 0 insp · 9 GMP | — | 0 programs |
| 40 |
Catalent
Bagsværd, Denmark (operating under Novo Holdings)
|
76.5 | 79.3 | 11 insp · 35 GMP | — | 0 programs |
| 41 |
BM
Biomay AG
Vienna, Austria
|
76.2 | 98.7 | 2 insp · 11 GMP | — | 0 programs |
| 42 |
CVC
CureVac (CDMO Services)
Tubingen, DE
|
75.3 | 100.0 | 0 insp · 7 GMP | — | 4 programs |
| 43 |
CA
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
|
75.1 | 79.3 | 1 insp · 0 GMP | Available | 0 programs |
| 44 |
MB
Miltenyi Biotec
Bergisch Gladbach, Germany
|
74.6 | 100.0 | 0 insp · 2 GMP | — | 8 programs |
| 45 |
CG
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
|
74.0 | — | — | — | 0 programs |
| 46 |
LZ
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
|
72.8 | 95.1 | 1 insp · 0 GMP | Limited | 0 programs |
| 47 |
AX
Axolabs (Nuvisan)
Kulmbach, Germany
|
72.5 | 98.8 | 1 insp · 0 GMP | — | 3 programs |
| 48 |
RT
ReiThera
Rome, IT
|
71.1 | 100.0 | 0 insp · 4 GMP | — | 1 programs |
| 49 |
BP
BSP Pharmaceuticals
Latina, Italy
|
67.6 | 77.4 | 7 insp · 12 GMP | — | 0 programs |
| 50 |
PP
PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
|
64.8 | 70.9 | 3 insp · 0 GMP | — | 0 programs |
| 51 |
RA
Recipharm Advanced Bio
Stockholm, Sweden (US operations: Watertown, MA; EU/global ATMP division of Recipharm AB)
|
63.0 | — | — | — | 0 programs |
| 52 |
HP
HIPRA Biotech Services
Amer, ES
|
63.0 | — | — | — | 0 programs |
| 53 |
AB
Asklepios BioPharmaceutical (AskBio)
Research Triangle, NC · San Sebastian, ES
|
59.7 | — | — | — | 10 programs |
| 54 |
CP
Cell and Gene Therapy Catapult
Stevenage, United Kingdom
|
59.0 | — | — | — | 0 programs |
| 55 |
EX
Excellos
La Rochelle, France
|
59.0 | — | — | — | 0 programs |
| 56 |
CZ
Cellex Cell Professionals
Cologne, Germany
|
59.0 | — | — | — | 0 programs |
| 57 |
AM
Anemocyte
Gerenzano, IT
|
59.0 | — | — | — | 0 programs |
| 58 |
DINAMIQS
Schlieren (Zurich), Switzerland
|
59.0 | — | — | Available | 0 programs |
| 59 |
EV
Evox Therapeutics
Oxford, UK
|
57.5 | — | — | — | 0 programs |
| 60 |
CV
CEVEC Pharmaceuticals
Cologne, DE
|
56.5 | — | — | — | 0 programs |
| 61 |
CX
CellGenix
Freiburg, DE
|
56.5 | — | — | — | 0 programs |
| 62 |
QB
Quantoom Biosciences
Gosselies, BE
|
56.5 | — | — | — | 0 programs |
| 63 |
EH
Ethris
Planegg, DE
|
56.5 | — | — | — | 0 programs |
| 64 |
PF
PlasmidFactory
Bielefeld, Germany
|
56.5 | — | — | — | 0 programs |
| 65 |
EXO
ExoXpert (EXO Biologics)
Liege, BE
|
56.5 | — | — | — | 0 programs |
| — |
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
|
Profiled | — | — | — | 0 programs |
| — |
BASF Pharma Solutions
Florham Park, NJ (global HQ: Ludwigshafen, Germany)
|
Profiled | — | — | — | 0 programs |
| — |
Adragos Pharma
Munich, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Icosagen
Tartu, Estonia
|
Profiled | — | — | — | 0 programs |
| — |
VIVEbiotech
San Sebastián, Spain
|
Profiled | — | — | — | 0 programs |
| — |
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
AUMOVIO SE
Frankfurt am Main, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Tecan Group / Tecan CDMO Solutions
Männedorf, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
Olon Group
Rodano (Milan), Italy
|
Profiled | — | — | — | 0 programs |
| — |
Olon
Rodano (Milan), Italy
|
Profiled | — | — | — | 0 programs |
| — |
Fermion (Orion Group)
Espoo, Finland
|
Profiled | — | — | — | 0 programs |
| — |
Marle Group
Nogent, France
|
Profiled | — | — | — | 0 programs |
| — |
53Biologics
Boecillo (Valladolid), Spain
|
Profiled | — | — | — | 0 programs |
| — |
Centillion Technology Limited
Newcastle upon Tyne, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Coriolis Pharma
Martinsried (Munich), Germany
|
Profiled | — | — | — | 0 programs |
| — |
Vetter Pharma International GmbH
Ravensburg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Eckert & Ziegler Radiopharma
Berlin, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Curium
Paris, France
|
Profiled | — | — | — | 0 programs |
| — |
Sterling Pharma Solutions
Cramlington, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Mabion S.A.
Konstantynów Łódźki, Poland
|
Profiled | — | — | — | 0 programs |
| — |
Boehringer Ingelheim BioXcellence
Ingelheim am Rhein, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Ardena
Ghent, Belgium
|
Profiled | — | — | — | 0 programs |
| — |
EUROAPI
Paris, France
|
Profiled | — | — | — | 0 programs |
| — |
Upperton Pharma Solutions
Nottingham, UK
|
Profiled | — | — | — | 0 programs |
| — |
Spur Therapeutics
London, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Touchlight
Hampton, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Eppendorf BioBLU
Hamburg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Biofarma Group
Padua, Italy
|
Profiled | — | — | — | 0 programs |
| — |
Glatt Pharmaceutical Services
Binzen, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Vectura (now Molex/Vectura)
Chippenham, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Hovione
Loures, Portugal (US sites: East Windsor, NJ and other US locations)
|
Profiled | — | — | — | 0 programs |
| — |
Novo Nordisk (Clayton, NC facility)
Bagsværd, Denmark (US manufacturing: Clayton, NC)
|
Profiled | — | — | — | 0 programs |
| — |
LFB Biomanufacturing
Les Ulis, France
|
Profiled | — | — | — | 0 programs |
| — |
AlfaSigma (Morpho CDMO)
Bologna, Italy
|
Profiled | — | — | — | 0 programs |
| — |
Cellistic
Mont-Saint-Guibert, Belgium
|
Profiled | — | — | — | 0 programs |
| — |
NegotiumBio LLC & GmbH
Basel, Switzerland (GmbH) / US entity (LLC)
|
Profiled | — | — | — | 0 programs |
| — |
Pierre Fabre CDMO
Toulouse, France
|
Profiled | — | — | — | 0 programs |
| — |
IDT Biologika GmbH
Dessau-Roßlau, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Curapath
Spain (exact city not disclosed publicly)
|
Profiled | — | — | — | 0 programs |
| — |
Croda Pharma (formerly Avanti Polar Lipids)
Snaith, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Richter-Helm / Gedeon Richter Biologics (Mammalian DP complement)
Budapest, Hungary
|
Profiled | — | — | — | 0 programs |
| — |
BioSpring GmbH
Frankfurt, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Pharmaron Biologics (Liverpool)
Liverpool, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
Thermo Fisher Scientific / Patheon – Monza, Italy
Monza, Italy
|
Profiled | — | — | — | 0 programs |
| — |
Biopharma Group
Swindon, United Kingdom
|
Profiled | — | — | — | 0 programs |
| — |
SEQENS Pharmaceutical Solutions (broader group)
Écully, France
|
Profiled | — | — | — | 0 programs |
| — |
AliveDx
Eysins, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
Delpharm
Saint-Rémy, France
|
Profiled | — | — | — | 0 programs |
| — |
Fresenius Kabi
Bad Homburg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Genmab (via ProfoundBio acquisition)
Copenhagen, Denmark
|
Profiled | — | — | — | 0 programs |
| — |
Genzyme (Sanofi)
Cambridge, MA (division of Sanofi, HQ: Paris, France)
|
Profiled | — | — | — | 0 programs |
| — |
Sanofi (Genzyme / Sanofi Manufacturing)
Paris, France
|
Profiled | — | — | — | 0 programs |
| — |
Aenova Group
Starnberg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Famar
Athens, Greece (European operations across multiple sites)
|
Profiled | — | — | — | 0 programs |
| — |
Recipharm
Stockholm, Sweden
|
Profiled | — | — | — | 0 programs |
| — |
Purna Pharmaceuticals NV
Puurs, Belgium
|
Profiled | — | — | — | 0 programs |
| — |
Axplora
Raubling, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Novasep
Lyon, France
|
Profiled | — | — | — | 0 programs |
| — |
Cerbios-Pharma
Lugano, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
ICROM S.r.l.
Concorezzo, Italy
|
Profiled | — | — | — | 0 programs |
| — |
Saltigo GmbH
Leverkusen, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Jetpharma SA
Balerna, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
Almac Group
Craigavon, United Kingdom
|
Profiled | — | — | — | 0 programs |
EMA and MHRA regulatory considerations for European-manufactured programs
European manufacturing for biopharma programs typically requires EMA-recognized GMP certification (via the EudraGMDP database) for EU material and MHRA GMP certification for UK material — post-Brexit, these are separate credentials even for CDMOs operating in both. The Signal Score's Quality Compliance pillar weighs EMA + MHRA GMP certificate density directly, so European CDMOs with dense certification typically rank higher on this pillar. Sponsors should verify certificate coverage for the specific manufacturing activity (drug substance vs drug product, dosage form) at the specific facility being considered — GMP certificates are activity-scoped, not blanket.
QP release requirements and how they affect CDMO selection
Every batch of medicinal product supplied to the EU market must be released by a Qualified Person (QP) — a specific regulatory role with statutory responsibility. This adds a process step (and typically a specific QP-service arrangement) that US-only manufacturing does not require. CDMOs with European operations either have in-house QPs (typical for larger diversified players) or coordinate with external QP services. For sponsors running EU trials or supplying EU commercial markets, this is a non-negotiable requirement to plan for. Individual CDMO profile pages capture facility-level detail; QP arrangements specifically are usually confirmed at RFP stage rather than published.
Which European CDMOs also cover FDA (US) regulatory geography?
European CDMOs with US FDA inspection history — indicating US regulatory posture — are candidates for sponsors running programs in both jurisdictions. The Signal Score's Quality Compliance pillar includes FDA inspection classifications, so a European CDMO with a strong FDA record typically ranks higher on that pillar than a European-only competitor. Cross-check with the US region ranking — CDMOs appearing in both rankings have demonstrated regulatory posture across both jurisdictions, which reduces tech-transfer risk for global programs.
Browse by modality within Europe
Modality-specific rankings for Europe-manufactured programs. Each page filters the modality's global ranking to CDMOs with confirmed Europe facilities.
Other regions